CN1155376C - 9-顺-视黄酸及其盐和酯的药物用途 - Google Patents
9-顺-视黄酸及其盐和酯的药物用途 Download PDFInfo
- Publication number
- CN1155376C CN1155376C CNB99126469XA CN99126469A CN1155376C CN 1155376 C CN1155376 C CN 1155376C CN B99126469X A CNB99126469X A CN B99126469XA CN 99126469 A CN99126469 A CN 99126469A CN 1155376 C CN1155376 C CN 1155376C
- Authority
- CN
- China
- Prior art keywords
- tretinoin
- pharmaceutically acceptable
- cell
- milligrams
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82392892A | 1992-01-22 | 1992-01-22 | |
US82374192A | 1992-01-22 | 1992-01-22 | |
US82378692A | 1992-01-22 | 1992-01-22 | |
US823928 | 1992-01-22 | ||
US823786 | 1992-01-22 | ||
US823741 | 1992-01-22 | ||
US82464792A | 1992-01-23 | 1992-01-23 | |
US824647 | 1992-01-23 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93100632A Division CN1068200C (zh) | 1992-01-22 | 1993-01-21 | 9-顺-视黄酸及其盐和酯的药物用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1256916A CN1256916A (zh) | 2000-06-21 |
CN1155376C true CN1155376C (zh) | 2004-06-30 |
Family
ID=27505866
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93100632A Expired - Fee Related CN1068200C (zh) | 1992-01-22 | 1993-01-21 | 9-顺-视黄酸及其盐和酯的药物用途 |
CNB99126469XA Expired - Fee Related CN1155376C (zh) | 1992-01-22 | 1999-12-15 | 9-顺-视黄酸及其盐和酯的药物用途 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93100632A Expired - Fee Related CN1068200C (zh) | 1992-01-22 | 1993-01-21 | 9-顺-视黄酸及其盐和酯的药物用途 |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0552624B1 (zh) |
JP (1) | JP3631259B2 (zh) |
CN (2) | CN1068200C (zh) |
AT (1) | ATE194077T1 (zh) |
AU (1) | AU667864B2 (zh) |
CA (1) | CA2087251C (zh) |
CY (1) | CY2251B1 (zh) |
CZ (1) | CZ282548B6 (zh) |
DE (1) | DE69328910T2 (zh) |
DK (1) | DK0552624T3 (zh) |
ES (1) | ES2148184T3 (zh) |
GR (1) | GR3034323T3 (zh) |
HU (2) | HU212734B (zh) |
IL (1) | IL104450A (zh) |
NO (1) | NO302274B1 (zh) |
NZ (1) | NZ245686A (zh) |
PH (1) | PH31621A (zh) |
PT (1) | PT552624E (zh) |
RU (1) | RU2119333C1 (zh) |
TW (1) | TW226329B (zh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968989A (en) | 1991-12-18 | 1999-10-19 | The Salk Institute For Biological Studies | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
ATE439341T1 (de) | 1991-12-18 | 2009-08-15 | Salk Inst For Biological Studi | Retinsäurederivate |
US7056954B2 (en) | 1991-12-18 | 2006-06-06 | The Salk Institute For Biological Studies | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
US5962731A (en) * | 1992-04-22 | 1999-10-05 | Ligand Pharmaceuticals Incorporated | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
US5780676A (en) * | 1992-04-22 | 1998-07-14 | Ligand Pharmaceuticals Incorporated | Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
US5549888A (en) * | 1994-01-31 | 1996-08-27 | Procter & Gamble | Aqueous topical anti-acne compositions of low pH |
US5534261A (en) * | 1995-01-17 | 1996-07-09 | University Of Southern California | Retinoid-based compositions and method for preventing adhesion formation using the same |
US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
US5821254A (en) * | 1995-02-17 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer |
US5807900A (en) * | 1995-03-31 | 1998-09-15 | Hoffmann-La Roche, Inc. | Method for identifying compounds having increased activity for the repair of skin photodamage |
AU5721096A (en) * | 1995-04-21 | 1996-11-07 | Ligand Pharmaceuticals Incorporated | Inhibition of apoptosis in cells expressing fas-ligand follo wing activation |
DE19523079A1 (de) * | 1995-06-26 | 1997-01-02 | Basf Ag | Ester und Amide der 9(Z)-Retinsäure |
KR19990045756A (ko) * | 1995-09-18 | 1999-06-25 | 윌리암 엘. 레스페스 | Rxr 작용제를 이용하는 niddm 치료 방법 |
WO1997010813A1 (en) | 1995-09-18 | 1997-03-27 | Ligand Pharmaceuticals Incorporated | Ppar gamma antagonists for treating obesity |
TW442459B (en) * | 1996-04-15 | 2001-06-23 | Hoffmann La Roche | Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof |
FR2765480B1 (fr) | 1997-07-07 | 1999-09-10 | Oreal | Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques |
WO1999005161A1 (en) | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
AU1707599A (en) * | 1998-03-20 | 1999-10-18 | Warner-Lambert Company | Retinoid-glitazone combinations |
TW550264B (en) | 1999-04-07 | 2003-09-01 | Sankyo Co | Amine derivated compounds and the pharmaceutical compositions thereof |
JP5249484B2 (ja) * | 2001-12-11 | 2013-07-31 | 第一三共株式会社 | 医薬組成物 |
US20050245440A1 (en) * | 2002-04-05 | 2005-11-03 | University Of Utah Research Foundation | Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 |
US20040122110A1 (en) * | 2002-09-06 | 2004-06-24 | Maccabee Mendy S. | Effect of vitamin A gel on paranasal sinus mucosal regeneration |
EP1527774A1 (en) * | 2003-11-03 | 2005-05-04 | Basilea Pharmaceutica AG | New formulation for retinoid-containing soft gelatin capsules |
JP4825957B2 (ja) * | 2005-03-29 | 2011-11-30 | 国立大学法人 鹿児島大学 | 抗腫瘍剤 |
AU2009352678B2 (en) | 2009-09-15 | 2015-05-21 | Eluminex Biosciences (Suzhou) Limited | Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
US20130317096A1 (en) * | 2010-04-16 | 2013-11-28 | Davos Life Science Pte Ltd | Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications |
EP2563350B1 (en) | 2010-04-19 | 2020-10-14 | Retinagenix Therapeutics, Inc. | Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
BR112014021602A2 (pt) | 2012-03-01 | 2021-06-08 | Quadra Logic Tech Inc | uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide |
JP6182728B2 (ja) * | 2012-11-02 | 2017-08-23 | 国立大学法人名古屋大学 | 幹細胞を標的とした薬効及び毒性の評価法 |
EP4215178A1 (en) | 2020-09-11 | 2023-07-26 | Chemyunion Ltda | Composition, use of the composition, cosmetic method and method for modulating the production of sebum |
WO2023168608A1 (en) * | 2022-03-08 | 2023-09-14 | Mastery Biotech Co., Ltd. | Pharmaceutical composition including retinoic acid and carbohydrate and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA713539B (en) * | 1970-06-23 | 1972-02-23 | Hoffmann La Roche | Pharmaceutical compositions |
EP0357646B1 (en) * | 1987-04-06 | 1995-03-22 | Daltex Medical Sciences, Inc. | Treatment of aged skin with oral 13-cis-retinoic acid |
US4994491A (en) * | 1988-12-14 | 1991-02-19 | Molecular Design International | Dermal uses of trans-retinoids for the treatment of cancer |
LU86969A1 (fr) * | 1987-08-12 | 1989-03-08 | Oreal | Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute |
ATE439341T1 (de) * | 1991-12-18 | 2009-08-15 | Salk Inst For Biological Studi | Retinsäurederivate |
-
1992
- 1992-12-17 CZ CS923728A patent/CZ282548B6/cs not_active IP Right Cessation
- 1992-12-24 TW TW081110357A patent/TW226329B/zh active
-
1993
- 1993-01-11 PT PT93100257T patent/PT552624E/pt unknown
- 1993-01-11 DK DK93100257T patent/DK0552624T3/da active
- 1993-01-11 AT AT93100257T patent/ATE194077T1/de not_active IP Right Cessation
- 1993-01-11 EP EP93100257A patent/EP0552624B1/en not_active Expired - Lifetime
- 1993-01-11 ES ES93100257T patent/ES2148184T3/es not_active Expired - Lifetime
- 1993-01-11 DE DE69328910T patent/DE69328910T2/de not_active Expired - Lifetime
- 1993-01-13 CA CA002087251A patent/CA2087251C/en not_active Expired - Fee Related
- 1993-01-15 NZ NZ245686A patent/NZ245686A/en not_active IP Right Cessation
- 1993-01-18 HU HU9300116A patent/HU212734B/hu not_active IP Right Cessation
- 1993-01-18 AU AU31861/93A patent/AU667864B2/en not_active Expired
- 1993-01-19 PH PH45577A patent/PH31621A/en unknown
- 1993-01-20 RU RU93005355A patent/RU2119333C1/ru not_active IP Right Cessation
- 1993-01-20 JP JP02342993A patent/JP3631259B2/ja not_active Expired - Fee Related
- 1993-01-20 IL IL104450A patent/IL104450A/xx not_active IP Right Cessation
- 1993-01-21 CN CN93100632A patent/CN1068200C/zh not_active Expired - Fee Related
- 1993-01-21 NO NO930206A patent/NO302274B1/no not_active IP Right Cessation
-
1995
- 1995-06-19 HU HU95P/P00256P patent/HU211167A9/hu unknown
-
1999
- 1999-12-15 CN CNB99126469XA patent/CN1155376C/zh not_active Expired - Fee Related
-
2000
- 2000-09-04 GR GR20000402010T patent/GR3034323T3/el not_active IP Right Cessation
-
2001
- 2001-12-11 CY CY0100043A patent/CY2251B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL104450A (en) | 1997-03-18 |
PH31621A (en) | 1999-01-12 |
RU2119333C1 (ru) | 1998-09-27 |
IL104450A0 (en) | 1993-05-13 |
CZ282548B6 (cs) | 1997-08-13 |
DK0552624T3 (da) | 2000-09-25 |
ES2148184T3 (es) | 2000-10-16 |
CY2251B1 (en) | 2003-07-04 |
CZ372892A3 (en) | 1993-12-15 |
AU667864B2 (en) | 1996-04-18 |
CA2087251C (en) | 2003-06-24 |
TW226329B (zh) | 1994-07-11 |
HU212734B (en) | 1996-10-28 |
NO930206D0 (no) | 1993-01-21 |
DE69328910D1 (de) | 2000-08-03 |
AU3186193A (en) | 1993-07-29 |
EP0552624A1 (en) | 1993-07-28 |
ATE194077T1 (de) | 2000-07-15 |
DE69328910T2 (de) | 2001-01-11 |
GR3034323T3 (en) | 2000-12-29 |
HUT63053A (en) | 1993-07-28 |
CN1074826A (zh) | 1993-08-04 |
JP3631259B2 (ja) | 2005-03-23 |
JPH06107542A (ja) | 1994-04-19 |
NO930206L (no) | 1993-07-23 |
PT552624E (pt) | 2000-10-31 |
CN1068200C (zh) | 2001-07-11 |
CN1256916A (zh) | 2000-06-21 |
NZ245686A (en) | 1995-05-26 |
HU211167A9 (en) | 1995-11-28 |
HU9300116D0 (en) | 1993-04-28 |
CA2087251A1 (en) | 1993-07-23 |
NO302274B1 (no) | 1998-02-16 |
EP0552624B1 (en) | 2000-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1155376C (zh) | 9-顺-视黄酸及其盐和酯的药物用途 | |
JP6865193B2 (ja) | 寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法 | |
CN1102852C (zh) | 含一氧化二氮的止痛药、消炎药和解热药的给药介质及含有这样的介质和药物的药物组合物 | |
CN1220488C (zh) | 用于治疗内皮机能障碍的非诺贝特和辅酶q10组合物 | |
CN1436197A (zh) | 新的n-酰基氨基酰胺类化合物、含它们的组合物以及它们的用途 | |
CN1400904A (zh) | 与雌激素联合的选择性雌激素受体调节剂 | |
CN1547475A (zh) | 采用电子转移试剂的磷酸酯衍生物进行皮肤治疗 | |
CN1474697A (zh) | 磷酸盐衍生物复合物 | |
CN1390126A (zh) | 治疗和/或抑制体重增加的方法 | |
CN1604772A (zh) | 化合物的透皮转运 | |
CN1187045C (zh) | 用于治疗牛皮癣的物质 | |
EP2922542A1 (en) | Methods and compositions for locally increasing body fat | |
TW201039858A (en) | Composition for alleviating ultraviolet radiation-induced damage | |
JPWO2013031729A1 (ja) | 糖尿病性心血管合併症の予防・治療剤 | |
CN1154652A (zh) | 去屑组合物 | |
CN1501804A (zh) | 软垂疣的缓解 | |
JP2664111B2 (ja) | 動物及び人における高コレステロール症及び高リポプロテインii型症及び性的挙動の刺激の処置に使用する高級一級脂肪族アルコールの混合物を含む医薬製剤 | |
CN1794967A (zh) | 含有白藜芦醇的美白抗氧化化妆合成物及其制备方法 | |
CN1219130A (zh) | 用于治疗眼部炎症的含硝酮化合物的组合物 | |
KR102173259B1 (ko) | 하이드란제놀을 유효성분으로 하는 지방형성 억제 및 체지방 감소용 조성물 | |
JP5703228B2 (ja) | 紫外線障害軽減経口組成物 | |
CN1552438A (zh) | 减弱阴道酸度及治疗阴道炎的药物及其用途 | |
CN1561220A (zh) | 炎症的治疗方法 | |
CN1398182A (zh) | 用于皮脂腺疾病的胆甾醇酯和蜡酯合成的双重抑制剂 | |
WO2022082071A1 (en) | Small molecule modulators of gp130 signaling pathways, topical formulations and method of us thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: BESLEY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HOFFMAN-LALUOAI LTD. Effective date: 20030418 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030418 Address after: Swiss Bin Ninggen Applicant after: Besli Medical Inc. Address before: Basel Applicant before: F. Hoffmann-La Roche AG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1030347 Country of ref document: HK |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040630 Termination date: 20110121 |